Clinical Trial Update: Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS) [Phase 3]

View source ↗

Summary

Phase 3 study exploring the mechanism of action of ocrelizumab and B-cell biology in relapsing and primary progressive multiple sclerosis; results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis
• Relapsing Multiple Sclerosis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Relapsing Multiple Sclerorsis, Multiple Sclerosis, Primary Progressive | Phase 3 | Status: COMPLETED | Results posted: 2024-06-04